$OCUL
Ocular Therapeutix, Inc.
XNAS•Health Care•Pharmaceutical Preparations
$7.06
▼-3.16%-$0.230
Subscriptions are live. Early access $24.99/mo, or start with 5 free premium days.
Plans & pricingDonateOcular Therapeutix, Inc.
XNAS•Health Care•Pharmaceutical Preparations
Why is OCUL down today? It is at $7.06 (-3.16%), and our scanner flagged it 141 times on unusual volume this month. See the catalyst behind the move, real-time alerts the moment OCUL spikes, and full due diligence on OCUL — key stats, earnings, dilution and insider activity. Free.
Our scanner flagged $OCUL 141 times in the last 30 days. Create a free account to track $OCUL, build a watchlist, and get instant unusual-volume alerts, with a full day of premium now and 5 more when you verify your email, no card needed.
No card · 5 premium days · join 800+ traders
The top plays and unusual-volume catches our scanner flags, emailed to you. No account needed.
No spam. Unsubscribe anytime. Not investment advice.
Here is the latest on OCUL from our scanner (live price and day move above). We have not detected an unusual-volume catalyst for OCUL today, so it is trading in line with its recent range. The moment our scanner flags unusual activity, the reason will appear here.
Latest filing144Notice of proposed insider sale (144)Oct 2, 2026 · 2 days ago| Insider | Action | Shares | % of position | Owns after | Value | Date |
|---|---|---|---|---|---|---|
Notman Donald Officer | Sold (automatic/other) | -1K | sold 0.3% | 367K | $11K at $10.24 | Aug 31, 26 |
Dugel Pravin Officer | Sold (automatic/other) | -50K 0.02% of company | n/a | n/a | n/a | Aug 25, 26 |
Dugel Pravin Officer | Acquired (grant/award) | +50K 0.02% of company | added 7.2% | 745K | n/a | Aug 25, 26 |
Dugel Pravin Officer | Sold (automatic/other) | -22K | sold 0.8% | 2.53M | $233K at $10.77 | Aug 24, 26 |
Heier Jeffrey S. Officer | Sold (automatic/other) | -3K | sold 1.0% | 318K | $36K at $10.78 | Aug 24, 26 |
Nayak Sanjay Officer | Sold (automatic/other) | -2K | sold 0.6% | 327K | $20K at $10.78 | Aug 24, 26 |
Kaiser Peter Officer | Sold (automatic/other) | -3K | sold 1.1% | 264K | $33K at $10.77 | Aug 24, 26 |
Dugel Pravin Officer | Sold (automatic/other) | -50K 0.02% of company | sold 1.9% | 2.55M | n/a | Jun 16, 26 |
Dugel Pravin Officer | Acquired (grant/award) | +50K 0.02% of company | added 7.2% | 745K | n/a | Jun 16, 26 |
Williams Leslie J. Director | Acquired (grant/award) | +14K | added 27% | 65K | n/a | Jun 10, 26 |
Raines Merilee Director | Acquired (grant/award) | +14K | added 30% | 61K | n/a | Jun 10, 26 |
Lindstrom Richard L Md Director | Acquired (grant/award) | +14K | added 5.7% | 261K | n/a | Jun 10, 26 |
Recent Form-4 filings via Nasdaq. Open-market buys are the signal worth watching. Grants and automatic (10b5-1) sells are routine. “% of position” is the share of that insider’s own holding the trade moved. Not investment advice.
Blend of news sentiment, today’s move, and community votes. Not investment advice.
News, unusual-volume alerts, AI-trader trades and community chatter - the whole story, newest first.
Comparable names in pharmaceutical preparations, closest in size first.
Here is the latest on OCUL from our scanner (live price and day move above). We have not detected an unusual-volume catalyst for OCUL today, so it is trading in line with its recent range. The moment our scanner flags unusual activity, the reason will appear here.
OCUL last traded at $7.06, down 3.16% on the day. The price and chart above update live during market hours (4 AM to 8 PM ET).
Ocular Therapeutix, Inc. (OCUL) is next expected to report earnings on Tuesday, November 3, 2026, about 30 days away. Earnings reports often cause large overnight gaps, so many traders manage risk around the date. The date can shift until the company officially confirms it.
The OCUL Live Alerts panel on this page streams real-time unusual volume (RVOL), momentum, halt and 200-EMA alerts from our scanner the moment they fire. Our scanner has flagged OCUL 141 times in the last 30 days.
OCUL (Ocular Therapeutix, Inc.) trades on XNAS, with a market cap of about $1.53B in the PHARMACEUTICAL PREPARATIONS sector.
That depends on your strategy and risk. Day traders look for volume, volatility and a clear trend. Use the live chart, RVOL alerts and 200-EMA context on this page to judge OCUL for yourself. This is not investment advice.
Live data from TheDesperateTrader scanner. Not investment advice.
$OCUL discussion
Sign in to ask a question or join the discussion.